GLUTAMINE

SynDRA canonical compound SYN0002641 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	CTPS1 \| GLUL \| GPRC6A \| PPAT
Indication	anxiety \| Crohn's disease \| diarrhea \| insomnia \| joint pain \| mucositis \| muscle pain \| peptic ulcer disease (PUD) \| ulcerative colitis
Disease area	dental \| gastroenterology \| neurology/psychiatry \| rheumatology

All known targets

L-Glutamine
glutamic acid amide
L-(+)-Glutamine
L-2-Aminoglutaramidic acid
levoglutamide
Levoglutamide
L-glutamine
Glutamina
FEMA NO. 3684
NSC-27421
Endari
Nutrestore
NutreStore
AES-14
Aesgen-14
Glutamine (INN)
L-glutamine (oral, short bowel syndrome), Emmaus
L-glutamine (topical, chemotherapy-induced mucositis), Aesgen
L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus
L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus/University of California Los Angeles
NSC 27421
glutamine (usp-rs)
2-aminoglutaramic acid
ENDARI
0RH81L854J
glutamine (usp monograph)
GLUTAMINE, L-
FEMA No. 3684
Cebrogen
Stimulina
glumin
Glutamic acid amide
Levoglutamid
Glavamin
Glutamic acid-5-amide
L-Glutamide
(S)-2,5-Diamino-5-oxopentanoic acid
Saforis